Low-Dose Interleukin-2 Therapy: A Driver of an Imbalance between Immune Tolerance and Autoimmunity

by Kosmaczewska, Agata
Published 2014

CTLA-4 affects expression of key cell cycle regulators of G0/G1 phase in neoplastic lymphocytes from patients with chronic lymphocytic leukaemia

by Ciszak, Lidia, Frydecka, Irena, Wolowiec, Dariusz, Szteblich, Aleksandra, Kosmaczewska, Agata
Published 2015

Patients with chronic lymphocytic leukaemia (CLL) differ in the pattern of CTLA-4 expression on CLL cells: the possible implications for immunotherapy with CTLA-4 blocking antibody

by Ciszak, Lidia, Frydecka, Irena, Wolowiec, Dariusz, Szteblich, Aleksandra, Kosmaczewska, Agata
Published 2015

Alterations in Both the Activatory and Inhibitory Potential of Peripheral Blood CD4+ T Cells in Rheumatoid Arthritis Patients Correlate with Disease Progression

by Kosmaczewska, Agata, Ciszak, Lidia, Swierkot, Jerzy, Szteblich, Aleksandra, Wiland, Piotr, Frydecka, Irena
Published 2013

Exogenous IL-2 Controls the Balance in Th1, Th17, and Treg Cell Distribution in Patients with Progressive Rheumatoid Arthritis Treated with TNF-Alpha Inhibitors

by Kosmaczewska, Agata, Ciszak, Lidia, Swierkot, Jerzy, Szteblich, Aleksandra, Kosciow, Katarzyna, Frydecka, Irena
Published 2014

Dysregulated Expression of Both the Costimulatory CD28 and Inhibitory CTLA-4 Molecules in PB T Cells of Advanced Cervical Cancer Patients Suggests Systemic Immunosuppression Relate...

by Kosmaczewska, Agata, Bocko, Dorota, Ciszak, Lidia, Wlodarska-Polinska, Iwona, Kornafel, Jan, Szteblich, Aleksandra, Masternak, Anna, Frydecka, Irena
Published 2011

Patients with the most advanced rheumatoid arthritis remain with Th1 systemic defects after TNF inhibitors treatment despite clinical improvement

by Kosmaczewska, Agata, Swierkot, Jerzy, Ciszak, Lidia, Szteblich, Aleksandra, Chrobak, Agnieszka, Karabon, Lidia, Partyka, Anna, Szechinski, Jacek, Wiland, Piotr, Frydecka, Irena
Published 2013